| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/23/2004 | WO2004081217A2 Method for increasing resistance against stress factors in plants |
| 09/23/2004 | WO2004081216A1 Alcohol dehydrogenase gene of acetic acid bacterium |
| 09/23/2004 | WO2004081215A1 Dna molecule coding for a gamma-tocopherol methyltransferase in maize and applications thereof |
| 09/23/2004 | WO2004081214A1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism |
| 09/23/2004 | WO2004081213A1 Dna having promoter activity in rice callus cell and utilization of the same |
| 09/23/2004 | WO2004081211A1 Technique of removing marker gene by transient expression of site-specific recombinase gene |
| 09/23/2004 | WO2004081210A1 GENE Lhd4 CONTROLLING PLANT FLOWERING AND UTILIZATION THEREOF |
| 09/23/2004 | WO2004081209A1 Genes controlling plant cell wall formation |
| 09/23/2004 | WO2004081204A1 Plant and plant cell having been modified in cell multiplication and development/differentiation |
| 09/23/2004 | WO2004081202A1 METHOD FOR PRODUCING TARGET PROTEINS BY DELETING OR AMPLIFYING ibpA AND/OR ibpB GENE CODING FOR INCLUSION BODY-ASSOCIATED PROTEINS |
| 09/23/2004 | WO2004081199A2 Novel compositions and methods for the treatment of immune related disease |
| 09/23/2004 | WO2004081189A2 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms |
| 09/23/2004 | WO2004081188A2 Non-toxic membrane-translocating peptides |
| 09/23/2004 | WO2004081184A2 Markerless transformation |
| 09/23/2004 | WO2004081183A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna |
| 09/23/2004 | WO2004081177A2 Intracellular signaling pathways in diabetic subjects |
| 09/23/2004 | WO2004081175A2 Methods and compositions for purification of nucleic acid from a host cell |
| 09/23/2004 | WO2004081174A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 09/23/2004 | WO2004081173A2 Nucleotide sequences regulating gene expression and constructs and methods utilizing same |
| 09/23/2004 | WO2004081171A2 Variants of enzymes of the alpha-amylase family |
| 09/23/2004 | WO2004081170A2 Progestin receptor-like protein |
| 09/23/2004 | WO2004081167A2 Expression vectors comprising the mcmv ie2 promoter |
| 09/23/2004 | WO2004081166A2 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine |
| 09/23/2004 | WO2004081150A2 Methyl esters of hydroxyl-containing fatty acids as biofuels |
| 09/23/2004 | WO2004081052A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | WO2004081050A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | WO2004081046A2 Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis |
| 09/23/2004 | WO2004081041A1 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
| 09/23/2004 | WO2004081040A2 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004081037A1 Inhibitors of extracellular hsp90 |
| 09/23/2004 | WO2004081033A2 Synthesis of proteins by cell-free protein expression |
| 09/23/2004 | WO2004081030A2 Peptides selectively lethal to malignant and transformed mammalian cells |
| 09/23/2004 | WO2004081026A2 Polypeptides |
| 09/23/2004 | WO2004081025A2 Differential megaplex immunoassay |
| 09/23/2004 | WO2004081024A2 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/23/2004 | WO2004081021A2 Oligonucleotide mimetics |
| 09/23/2004 | WO2004080579A2 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080448A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases |
| 09/23/2004 | WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080419A2 Humanized antibodies that recognize beta amyloid peptide |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080406A2 Therapeutic compositions |
| 09/23/2004 | WO2004080395A2 Methods and compositions for cancer treatment |
| 09/23/2004 | WO2004080386A2 Optimization of bacterial sucab expression by promoter mutagenesis for efficient l-glutamic acid production |
| 09/23/2004 | WO2004080378A2 Methods and tools for screening active rna in cellulo |
| 09/23/2004 | WO2004080287A2 Method of killing cancer cells |
| 09/23/2004 | WO2004080202A2 Production of plants with improved digestibility having an inactive peroxidase |
| 09/23/2004 | WO2004080162A2 Integrase mediated avian transgenesis |
| 09/23/2004 | WO2004080148A2 Novel nucleic acids and polypeptides |
| 09/23/2004 | WO2004072293A3 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 09/23/2004 | WO2004069993A3 Non-touch zona pellucida microdrilling of a single - cell embryo with a 1.48 um laser beam for introduction of retrovirus |
| 09/23/2004 | WO2004066914A3 Variant integrin polypeptides and uses thereof |
| 09/23/2004 | WO2004066909A3 Method for identifying novel treatments of inflammatory disease in the gut |
| 09/23/2004 | WO2004065602B1 Method of identifying the epithelial-mesenchymal transition of mesothelial cells (emtmc) and identifying emtmc-modulating compounds, pharmaceutical compositions and use thereof in the diagnosis and treatment of diseases associated with emtmc |
| 09/23/2004 | WO2004063354A3 Compositions and methods for characterizing and regulating wnt pathways |
| 09/23/2004 | WO2004061097A3 Crystal structure of glutamate racemase (muri) |
| 09/23/2004 | WO2004061095A3 Micro-organism strains having an inactive phor/phon operon for carrying out a method for the overproduction of metabolites, in particular exhibiting an antibiotic and enzymatic activity |
| 09/23/2004 | WO2004060052A3 Transgenic mice expressing human cd20 and/or cd16 |
| 09/23/2004 | WO2004058963A3 A novel gene osisap1 of rice confers tolerance to stresses and a method thereof |
| 09/23/2004 | WO2004058812A3 Ribose-phosphate pyrophosphokinase polypeptides and structures |
| 09/23/2004 | WO2004055166A3 Multi-antigenic alphavirus replicon particles and methods |
| 09/23/2004 | WO2004053117A3 Serine protease |
| 09/23/2004 | WO2004051265A3 Fish disease models and uses thereof |
| 09/23/2004 | WO2004050870A3 Genetic switches for the detection of fusion proteins |
| 09/23/2004 | WO2004046185A3 Intracellular antibodies |
| 09/23/2004 | WO2004042024A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF HIF-1 ALPHA |
| 09/23/2004 | WO2004039842A3 Humanized tissue factor antibodies |
| 09/23/2004 | WO2004037858A3 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof |
| 09/23/2004 | WO2004035784A3 Soluble rna polymerase protein and methods for the use thereof |
| 09/23/2004 | WO2004031415A3 Methods and compositions for rapid development of screening assays nuclear receptors |
| 09/23/2004 | WO2004031349A3 Polynucleotides and polypeptides in plants |
| 09/23/2004 | WO2004030634A3 Therapeutic compositions |
| 09/23/2004 | WO2004029575A3 Methods for diagnosing htlv-i-mediated diseases |
| 09/23/2004 | WO2004029215A3 Conditional gene expression using rnai |
| 09/23/2004 | WO2004027092A3 Dna chips used for bioprocess control |
| 09/23/2004 | WO2004020577A3 Processes for inhibiting gene expression using polynucleotides |
| 09/23/2004 | WO2004018710A3 Diagnosis of chronic rejection |
| 09/23/2004 | WO2004010947A3 Humanized antibodies against human 4-1bb |
| 09/23/2004 | WO2004009782A3 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 09/23/2004 | WO2004009781A3 Process for regulating gene expression |
| 09/23/2004 | WO2004006656A3 Transgenic bioluminescent plants |
| 09/23/2004 | WO2003106621A3 Anti-igf-i receptor antibody |
| 09/23/2004 | WO2003102157A3 Synthetic antibody phage libraries |
| 09/23/2004 | WO2003100032A3 Dwarfism genes and dwarf plants |
| 09/23/2004 | WO2003096969A3 Novel lambda phage display system and the process |
| 09/23/2004 | WO2003095671A8 Method of diagnosis and treatment for affective disorders |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003087815A3 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/23/2004 | WO2003070880A3 Bacteria with reduced genome |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | WO2003061681A3 Proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/23/2004 | WO2003060103A3 Minimal dna binding domain polynucleotides, polypeptides, and uses thereof |
| 09/23/2004 | WO2003046204A3 Humanized collagen antibodies and related methods |
| 09/23/2004 | WO2003020956A3 Nucleid acid compositions conferring herbicide resistance |
| 09/23/2004 | WO2003020907A3 Histamine receptor h4 polynucleotides |
| 09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |